Business Wire Feed
SEQSTER Launches 1-Click Data Refinery™ to Power Scalable AI Across Clinical Trials
Enterprise-ready harmonization engine delivers AI-ready clinical data for faster cohort discovery, trial screening, feasibility analysis, and ongoing study execution.SAN DIEGO--(BUSINESS WIRE)--SEQSTER PDM, Inc. (“SEQSTER”), the leading healthcare technology company and the data connection, collection, and more...
FNIH Biomarkers Consortium Study Shows “Clock Model” Blood Test Can Predict Onset of Alzheimer’s Symptoms Years in Advance
The “clock model” can use a single blood test to estimate the onset of symptoms within 3-4 years. A new web-based tool visualizes how Alzheimer’s biomarkers change over time and relate to symptoms. These tools more...
GekkoVet and Royal Canin Enter Latin America with Mexico Launch, Opening a New Continent in their Global Partnership
HELSINKI & MEXICO CITY--(BUSINESS WIRE)--GekkoVet, the Finnish leader in AI-powered clinical decision support for veterinarians, and Royal Canin, a global pioneer in pet health through nutrition, announce the launch of their strategic collaboration in Mexico. more...
From Chile’s Forests to Fields, Syngenta Brings Botanical-Based Biofungicide to the Americas
BASEL, Chile & DAVIS, Calif.--(BUSINESS WIRE)--Innovation often begins by observing nature and drawing inspiration from it, a wisdom deeply rooted in the ancient Mapuche culture of Chile. Known and used for centuries, the Mapuche have more...
Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 2026
LYON, France--(BUSINESS WIRE)--#Biotech--Brenus Pharma, a clinical-stage biotechnology company pioneering in vivo “off-the-shelf” immunotherapies, announced the selection of an abstract for a poster presentation at the American Association for Cancer Research Immuno-Oncology (AACRIO) annual conference (February more...
ENHERTU® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer
Based on DESTINY-Breast05 phase 3 trial results, which showed ENHERTU reduced the risk of invasive disease recurrence or death by 53% compared to T-DM1 If approved, Daiichi Sankyo and AstraZeneca’s ENHERTU has the potential to more...
Hana Health by DSS Imagetech Partners with Overture Life to Bring World-First Automated Egg-Freezing Technology to India
DaVitri is an automated egg-freezing platform that enables fertility clinics to standardize one of the most technically demanding steps in IVF. It allows both small and large centralized laboratories to process significantly more procedures while more...
Lennard High School Unveils Transformed Weight Room in Partnership with Wellpoint and Impact Fitness Foundation
RUSKIN, Fla.--(BUSINESS WIRE)--#CommunityImpact--Earl J. Lennard High School today celebrated the unveiling of its newly transformed weight room, made possible through a partnership with Wellpoint and the Impact Fitness Foundation, a national nonprofit focused on expanding more...
LEO Pharma Delivers 10% Revenue Growth in 2025 and More Than Doubles Adjusted EBITDA Margin
BALLERUP, Denmark--(BUSINESS WIRE)--In 2025, LEO Pharma delivered a third consecutive year of double‑digit revenue growth (CER), at the upper end of guidance, and achieved a significant improvement in profitability, returning to positive net profit and more...
Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference
MARSEILLE, France--(BUSINESS WIRE)--#Biotech--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate more...
Lindora Appoints JJ Virgin as Chief Metabolic Health Officer to Lead Proprietary “Muscle-First: Everything Else Follows” Programming
LOS ANGELES--(BUSINESS WIRE)--#darshanshah--Lindora, the leader in medical weight loss with a 55-year legacy, today announced the appointment of JJ Virgin as Chief Metabolic Health Officer, strengthening the brand’s commitment to innovation, measurable outcomes, and long-term more...
Flashpoint Therapeutics Announces Major Publication on Novel HPV Cancer Vaccine
Study in Science Advances shows proprietary Spherical Nucleic Acid (SNA) vaccine platform slows tumor growth and extends survival in preclinical models of HPV-related cancerEVANSTON, Ill.--(BUSINESS WIRE)--Flashpoint Therapeutics, a biotechnology company pioneering a new class of more...
Summit Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results & Operational Progress Call on February 23, 2026
Conference Call to be Held at 4:30pm ETMIAMI--(BUSINESS WIRE)--$SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) will host an earnings call to announce its fourth quarter and full year 2025 financial results and more...
Advocates Rally at Florida Capitol to Protect Lifesaving HIV Drug Access for Thousands, says AHF
RALLY: Wednesday, Feb. 18, 10:30 a.m., Tallahassee Capitol RALLY: Thursday, Feb. 19, 10:30 a.m., Tallahassee Capitol Two-day rally calls on Florida to maintain ADAP coverage for 16,000 people living with HIV who face loss of more...
Kenvue Reports Fourth Quarter and Full Year 2025 Results
Q4 Net Sales 3.2%; Organic Sales1 1.2% Q4 Diluted EPS was $0.17; Adjusted Diluted EPS1 was $0.27 FY'25 Net Sales (2.1)%; Organic Sales (2.2)% FY'25 Diluted EPS was $0.76; Adjusted Diluted EPS was $1.08 SUMMIT, more...
agilon health to Participate in Upcoming Conferences
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that its management team will participate in a fireside chat at the following conferences: more...
Phreesia Sets Release Date for Fiscal Fourth Quarter and Fiscal Year 2026 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal fourth quarter and fiscal year 2026 financial results after the close of market trading on Monday, March 30, 2026. more...
Spruce Biosciences to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., more...
Exa Capital Acquires StaffReady
DALLAS--(BUSINESS WIRE)--Exa Capital, a strategic long-term operator that buys and holds enterprise software companies forever, is proud to announce the acquisition of StaffReady, a leading SaaS platform for clinical workforce management in healthcare. Founded in more...
Dialed Moods Advances Biohacking Wellness with Nature-Driven Supplement Innovation
New supplements deliver functional support for modern health, energy, clarity and daily optimizationCOSTA MESA, Calif.--(BUSINESS WIRE)--Dialed Moods, a leading health and wellness company, expands its focus in 2026 on holistic biohacking through plant-powered formulations. Dialed more...
Prime Healthcare Foundation Expands National Footprint as Central Maine Healthcare Joins Its Award-Winning System
Foundation grows to 21 hospitals, strengthening medical education, quality, and access to care in MaineONTARIO, Calif.--(BUSINESS WIRE)--#AccessToCare--Prime Healthcare Foundation (PHF), a public nonprofit 501(c)(3) charity, announced today that Central Maine Healthcare (CMH) has officially joined more...
VB Spine Announces Intent to Acquire Exclusive Rights to Augmedics’ Spine Platform
Transaction will expand VB Spine’s enhanced visualization portfolio to include augmented reality navigation with the Augmedics xvision Spine System®NEW YORK & CHICAGO--(BUSINESS WIRE)--VB Spine LLC (“VB Spine”), the largest privately held spine company, today announced more...
Europe Oncology Genomics Tracker Captures Oncologist Perspectives Across Major European Markets – Data Report by DeciBio Consulting LLC
LOS ANGELES--(BUSINESS WIRE)--#MRD--A new survey-based Genomics Tracker focused on the EU-5 (France, Germany, Italy, Spain, and the United Kingdom) by DeciBio Consulting LLC provides updated insight into how genomics technologies are being evaluated, adopted, and more...
LocumTenens.com Wins ClearlyRated’s 2026 Best of Staffing Client and Talent Awards for Service Excellence
Fewer Than 1% of All Staffing Companies in the U.S. and Canada Achieve Both Best of Staffing Client and Talent AwardsALPHARETTA, Ga.--(BUSINESS WIRE)--LocumTenens.com, a pioneer in healthcare staffing solutions, announced today that it has won more...
Worldwide Clinical Trials Completes Acquisition of Catalyst Clinical Research
CRO expands oncology, adds functional service provider capabilities, strengthens global reach, and accelerates technology to enhance customer valueRESEARCH TRIANGLE PARK, N.C. & NOTTINGHAM, England--(BUSINESS WIRE)--#CROleader--Worldwide Clinical Trials (“Worldwide” or the “Company”), a global contract research more...